Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.

Main|Search|PHGKB




Last Posted: Jul 27, 2017

---

• Is pharmacogenetic-guided treatment cost-effective? No one size fits all!
  S Grosse et al, CDC Blog Post, July 24, 2017
• Impact of CYP2D6 genotype on amitriptyline efficacy for the treatment of diabetic peripheral neuropathy: a pilot study.  
  Chaudhry Mamoonah et al. Pharmacogenomics 2017 Apr 18(5) 433-443
• Incorporating Pharmacogenomics into Health Information Technology, Electronic Health Record and Decision Support System: An Overview.  
  Alanazi Abdullah et al. Journal of medical systems 2017 Feb 41(2) 19
• Pharmacogenetic dosing of warfarin in the Han-Chinese population: a randomized trial.  
  Wen Ming-Shien et al. Pharmacogenomics 2017 Feb 18(3) 245-253
• A cost-effectiveness analysis of maternal CYP2D6 genetic testing to guide treatment for postpartum pain and avert infant adverse events.  
  Moretti M E et al. The pharmacogenomics journal 2017 Jul
• Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory.  
  Vo Teresa T et al. Pharmacotherapy 2017 Jul
• Road to Recovery: New personalized treatments and technologies are helping people free themselves from opioid addiction.  
  Genome Magazine, Summer 2017
• Collaborative counseling considerations for pharmacogenomic tests.  
  Zierhut Heather A et al. Pharmacotherapy 2017 Jul
• Educating patients and providers through comprehensive pharmacogenetic test reports.  
  Haga Susanne B et al. Pharmacogenomics 2017 Jul
• Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop  
  National Academies Workshop Report, July 10, 2017
• Feasibility of clinical pharmacist-led CYP2C19 genotyping for patients receiving non-emergent cardiac catheterization in an integrated health system. 
  Johnson Samuel G et al. Pharmacy practice 15(2) 946
• New Data on Opioid Use and Prescribing in the United States.  
  Schuchat Anne et al. JAMA 2017 Jul
• Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.  
  Dotson W D et al. Clinical pharmacology and therapeutics 2014 Apr 95(4) 394-402
• Proposal for a Pharmacogenetic Decision Algorithm.  
  Alzghari Saeed K et al. Cureus 2017 May 9(5) e1289
• The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.  
  Papastergiou John et al. Journal of the American Pharmacists Association : JAPhA 2017 Jul
• The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.  
  Manson Lisanne En et al. Pharmacogenomics 2017 Jul

more